IGC Pharma, Inc. (IGC) analyst actions
Rating and price-target actions on IGC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the IGC overview →
4 measured IGC analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts | Press release | -0.17% | -2.56% | |
| Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts | Press release | +4.34% | -0.28% | |
| IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target | Press release | +0.11% | +4.57% | |
| IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target | Press release | +7.11% | +8.21% |
Keep exploring
More IGC: earnings → · SEC filings → · IGC overview →